Amgen Inc.

Tularik Limited

Rapt Therapeutics, Inc.

Gene Cutler

Scott Powers

Jianxin Yang

Jacob Bradley Schwarz

David Juergen Wustrow

Jack Maung

Akinori Okano

Paul D Kassner

Dennis X Hu

Berenger Biannic

Paul Robert Leger

Xinping Han

Kyle Young

Silpa Suthram

William Yew-Wai Ho

Brian Russell Wong

Yamini Ohol-Gupta

Kim Coign Quon

Jennifer Joy Kordich

Disclosed herein are therapeutic methods of administering compounds that modulate the C&#x2014;C chemokine receptor type 4 (CCR4) for the treatment of Epstein Bar virus (EBV) positive cancers and malignancies.

Anticancer agents

Disclosed herein, inter alia, compounds and methods of use thereof for the modulation of USP7 activity.

Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof

The present invention provides fusion proteins expressed by cancer cells, antibodies and other antigen-binding agents that specifically bind to the fusion proteins, and compositions and methods for using the antibodies and other antigen-binding agents to detect, characterize, and treat cancer.

Antibodies which bind to SCNN1A/TNFRSF1A fusion proteins and methods of use thereof

The invention provides isolated nucleic acid and amino acid sequences of four novel G-protein coupled receptors that are amplified in breast cancer cells, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.

G-protein coupled receptors

G-protein coupled receptors amplified in breast cancer

G-protein coupled receptor BCA-GPCR-3

Growing community of inventors

San Francisco, CA, United States of America

Gene Cutler